• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:李玥璇,梁丽红,许茹,程培萱,肖超妮.石菖蒲抗癫痫活性成分α-细辛醇鼻腔给药大鼠的药代动力学研究[J].药学研究,2021,40(10):631-637[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2355次   下载 2648次 本文二维码信息
码上扫一扫!
石菖蒲抗癫痫活性成分α-细辛醇鼻腔给药大鼠的药代动力学研究
李玥璇,梁丽红,许茹,程培萱,肖超妮
字体:加大+|默认|缩小-
(西北大学生命科学学院,陕西 西安 710069)
摘要:
目的 研究石菖蒲抗癫痫活性成分α-细辛醇鼻腔给药的药代动力学特征和脑组织分布。方法 采用HPLC方法分析比较鼻腔给药、灌胃给药和静脉注射α-细辛醇大鼠血浆的药代动力学特性和脑组织分布情况。结果 鼻腔给药α-细辛醇Cmax=11.39 ± 1.30 μg·mL-1,Tmax= 2 min,这与静脉给药α-细辛醇的参数相当,而灌胃给药α-细辛醇Cmax= 6.71 ± 0.78 μg·mL-1,Tmax=10 min。鼻腔给药和灌胃给药的生物利用度分别为70.57 %和19.31 %。鼻腔给药α-细辛醇在海马、小脑、嗅球和大脑皮层均有分布,且在嗅球的脑靶向性最高。结论 鼻腔给药α-细辛醇通过鼻脑通路进入脑部,吸收更迅速、生物利用度更高、脑靶向性更好,是一种治疗癫痫疾病的有效途径。
关键词:  α-细辛醇  鼻腔给药  癫痫
DOI:10.13506/j.cnki.jpr.2021.10.001
基金项目:陕西省重点研发计划-国际科技合作计划重点项目(No.2018KWZ-05)
出版日期:2021-10-25
Study on pharmacokinetics of α-asaronol from Rhizoma Acori Tatarinowii by intranasal administration in rats
LI Yuexuan,LIANG Lihong,XU Ru,CHENG Peixuan,XIAO Chaoni
(College of Life Sciences, Northwest University, Xi’an, China 710069)
Abstract:
Objective To investigate rat plasma pharmacokinetics and brain distribution of α-asaronol from Rhizoma Acori Tatarinowii by intranasal administration. Methods RP-HPLC method was applied to compare pharmacokinetics and brain distribution of α-asaronol by different routes including intranasal administration, intragastric administration and intravenous injection. Results Maximum concentration in plasma (Cmax) of α-asaronol for intranasal administration was 11.39 ± 1.30 μg·mL-1 and the peak time (Tmax) was 2 min, which were comparable to those for intravenous injection, whiles Cmax was 6.71 ± 0.78 μg·mL-1 and Tmax was 10 min for intragastric administration. Compared with intravenous injection, the bioavailability of α-asaronol by intranasal and intragastric administration was 70.57% and 19.31%, respectively. α-asaronol was distributed in hippocampus, cerebellum, olfactory bulb and cerebral cortex after intranasal administration, especially that the brain targeting is highest in olfactory bulb. Conclusion Intranasal administration can import α-asaronol into the brain by nasal-brain pathway, which is an effective route to treat epilepsy with faster absorption, higher bioavailability and better brain targeting.
Key words:  α-asaronol  Epilepsy  Intranasal administration
今日访问量:2485    总访问量:55338923
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司